Braat D D, Schoemaker J
Department of Obstetrics and Gynecology, Academic Hospital Vrije Universiteit, Amsterdam, The Netherlands.
Fertil Steril. 1991 Dec;56(6):1054-9. doi: 10.1016/s0015-0282(16)54716-5.
To find the treatment regimen giving a maximum chance of ovulation and a minimal chance of multiple follicular development in pulsatile gonadotropin-releasing hormone (GnRH) therapy in patients with hypothalamic amenorrhea.
We propectively studied the endocrinology of cycles induced with 5, 10, and 20 micrograms GnRH pulse doses, randomly assigned per patient, comparing this with the endocrinology of spontaneous menstrual cycles.
All patients were treated at the Academic Hospital of the Vrije Universiteit, Division of Reproductive Endocrinology and Fertility.
Fifteen patients with hypothalamic amenorrhea were treated for one to three cycles; 14 normally cycling volunteers were studied for one cycle.
Number of ovulations per pulse dose; luteinizing hormone, follicle-stimulating hormone, total urinary estrogens (Es), and pregnanediol were measured per cycle day and per stimulation day.
The endocrinology of all ovulatory cycles remained within the normal range. First treatment cycles showed significantly higher ovulation rates compared with subsequent cycles. Significantly more anovulation was observed in cycles with 5-micrograms pulse doses. Luteal Es were significantly higher in induction cycles compared with controls.
The optimum treatment regimen should be to start induction with 5 micrograms/pulse in the first cycle and to raise the dose to 10 micrograms/pulse in subsequent cycles, regardless of the outcome of the first cycle. After ovulation, the pulse interval should be changed to 240 minutes.
在对下丘脑性闭经患者进行脉冲式促性腺激素释放激素(GnRH)治疗时,寻找能使排卵机会最大化且多卵泡发育机会最小化的治疗方案。
我们前瞻性地研究了每位患者随机分配的5微克、10微克和20微克GnRH脉冲剂量诱导周期的内分泌情况,并将其与自然月经周期的内分泌情况进行比较。
所有患者均在自由大学学术医院生殖内分泌与生育科接受治疗。
15名下丘脑性闭经患者接受了1至3个周期的治疗;14名月经周期正常的志愿者接受了1个周期的研究。
每个脉冲剂量的排卵次数;在每个周期日和每个刺激日测量促黄体生成素、促卵泡生成素、尿总雌激素(Es)和孕二醇。
所有排卵周期的内分泌情况均保持在正常范围内。与后续周期相比,首次治疗周期的排卵率显著更高。在5微克脉冲剂量的周期中观察到的无排卵情况明显更多。与对照组相比,诱导周期中的黄体期Es显著更高。
最佳治疗方案应为在第一个周期开始时以5微克/脉冲进行诱导,在后续周期中将剂量提高至10微克/脉冲,无论第一个周期的结果如何。排卵后,脉冲间隔应改为240分钟。